Fig 7.

Valaciclovir treatment leads to a less differentiated IAV-specific CD8⁺ T-cell phenotype following influenza challenge. (A) The percentage of NP tetramer-specific CD8⁺ T cells within the BAL (n = 3 to 6), CMLN (n = 4 to 5), and spleen (n = 3 to 6). Shown also are results of analyses of memory subsets (B) and surface phenotypes (C) of NP tetramer-specific CD8⁺ T cells in CMLN (mean ± SEM). The data were analyzed by 2-way ANOVA plus Bonferroni's posttest correction (*, P < 0.05; **, P < 0.01).